Pharmacovigilance consulting firms sit at the intersection of regulatory obligation and scientific rigor. Their clients — pharmaceutical companies, biotech developers, and medical device manufacturers — rely on them to maintain compliant safety databases, prepare periodic safety reports, and respond to health authority queries on strict timelines. The International Council for Harmonisation (ICH) E2A guideline mandates expedited reporting of serious unexpected adverse events within 7 to 15 days, and PSUR submission deadlines under ICH E2C(R2) are fixed to product registration anniversaries across multiple markets.
Meeting these deadlines requires not just safety scientists and regulatory writers, but a robust coordination infrastructure. Virtual assistants are filling that infrastructure role at an increasing number of PV consulting firms.
Adverse Event Intake Coordination
Adverse event cases arrive through multiple channels: spontaneous reports from patients and healthcare providers, literature cases, clinical trial overflow, and health authority forwarded reports. Each case must be triaged for seriousness, expectedness, and causality — but before that triage begins, the case must be received, logged, and routed to the appropriate safety scientist with all source documentation attached.
Virtual assistants manage this intake layer. They monitor designated AE inboxes, receive and acknowledge reporter contacts, log case information into the safety database (operating within platforms like Argus Safety, Veeva Vault Safety, or ArisG), and attach source documents. For literature surveillance programs, VAs download and organize journal articles flagged through automated search tools such as Embase or PubMed alert feeds, routing potential cases to the medical officer for assessment. A 2025 survey by the Drug Information Association (DIA) found that PV departments spend an average of 22 percent of staff time on case intake administration — time that VAs can absorb at a fraction of the cost of a full-time safety associate.
PSUR Preparation Support
Periodic Safety Update Reports are among the most document-intensive deliverables in pharmacovigilance. A single PSUR for a marketed product may require compilation of line listings from multiple regions, summary tabulations, CIOMS I forms, risk-benefit narrative sections, and appendices covering regulatory actions taken during the reporting period. The preparation work is substantial even before a safety scientist writes a single line of narrative.
Virtual assistants support PSUR preparation by pulling and formatting line listings from the safety database per the PSUR data lock point, organizing CIOMS forms, assembling appendices of regulatory actions and labeling changes, and maintaining the document tracking log against the submission timeline. With document assembly handled, the safety scientist focuses on signal evaluation, benefit-risk analysis, and narrative authoring.
Health Authority Communication Management
Pharmacovigilance consulting firms managing safety for products registered in multiple markets receive a steady stream of health authority queries — requests for additional case information, clarification on expedited reports, and responses to PSUR assessments. Each query carries a response deadline, and missing a health authority deadline can trigger regulatory action for the client.
Virtual assistants maintain a health authority communication log, track incoming queries by market and deadline, prepare draft response cover letters for regulatory affairs review, and follow up on pending acknowledgments. For firms managing 20 or more products across multiple markets, this query management function alone justifies dedicated VA support.
Compliance and Quality Support
VAs also support ongoing quality activities: maintaining standard operating procedure (SOP) version control files, tracking training completion records for PV staff, and preparing audit-readiness documentation packages. These are essential functions that frequently fall behind when the scientific team is consumed by submission deadlines.
Pharmacovigilance consulting firms ready to scale their coordination infrastructure can access trained virtual assistants with PV workflow experience at Stealth Agents.
Sources
- ICH E2A — Clinical Safety Data Management: Definitions and Standards for Expedited Reporting
- ICH E2C(R2) — Periodic Benefit-Risk Evaluation Report (PBRER)
- Drug Information Association (DIA) — PV Staff Time Allocation Survey, 2025
- Stealth Agents Research, 2026